Published in JAMA on December 07, 1970
Antimicrobial resistance of Shigella isolates causing traveler's diarrhea. Antimicrob Agents Chemother (1994) 1.36
Antimicrobial resistance in Shigella flexneri and Shigella sonnei in Hong Kong, 1986 to 1995. Antimicrob Agents Chemother (1998) 1.16
Comparative efficacies of pivmecillinam and ampicillin in acute shigellosis. Antimicrob Agents Chemother (1984) 1.08
Comparative efficacies of single intravenous doses of ceftriaxone and ampicillin for shigellosis in a placebo-controlled trial. Antimicrob Agents Chemother (1986) 0.91
Sulfamethoxazole-trimethoprim-resistant Shigella flexneri in northeastern Brazil. Antimicrob Agents Chemother (1984) 0.83
Susceptibility of Shigella species to erythromycin. Antimicrob Agents Chemother (1982) 0.79
A new look at infectious gastroenteritis. West J Med (1974) 0.75
Shigella dysenteriae type 1--severe dysentery and sepsis with hematologic, hepatic and renal complications. West J Med (1974) 0.75
Infectious diseases: annual review of significant publications. Postgrad Med J (1971) 0.75
Importation of Shiga bacillus dysentery into California. Clinical and public health significance. Calif Med (1972) 0.75
Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N Engl J Med (1984) 2.76
Cryptosporidiosis: an outbreak associated with drinking water despite state-of-the-art water treatment. Ann Intern Med (1996) 2.65
Perinatal hepatitis B virus transmission in the United States. Prevention by passive-active immunization. JAMA (1985) 2.48
Cystic thyroid nodules. The dilemma of malignant lesions. Arch Intern Med (1990) 2.40
Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res (1989) 2.35
Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst (1990) 2.23
Day case laparoscopy: a survey of postoperative pain and an assessment of the value of diclofenac. Anaesthesia (1991) 2.12
Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission. JAMA (1987) 2.08
Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group. J Gastroenterol Hepatol (2000) 2.06
Coagulation defects associated with massive blood transfusions. Ann Surg (1971) 2.03
Effective audiovisual presentation: proper citation of sources. AJR Am J Roentgenol (1991) 1.99
Hepatitis-associated antigen and hepatocellular carcinoma in Taiwan. Ann Intern Med (1971) 1.89
Intrahepatic, nucleocapsid antigen-specific T cells in chronic active hepatitis B. J Immunol (1987) 1.85
Postnatal neuronal proliferation in mice lacking Ink4d and Kip1 inhibitors of cyclin-dependent kinases. Proc Natl Acad Sci U S A (1999) 1.66
A reanalysis of the factors influencing basal metabolic rate in normal adults. Am J Clin Nutr (1980) 1.64
Lymphocyte stimulation in hepatitis B infections. N Engl J Med (1975) 1.60
Racial differences in responses to therapy with interferon in chronic hepatitis C. Consensus Interferon Study Group. Hepatology (1999) 1.59
Septic complications of war wounds. JAMA (1972) 1.58
Lack of response to recombinant hepatitis B vaccine in nonresponders to the plasma vaccine. JAMA (1988) 1.56
Nonviral risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, California. J Natl Cancer Inst (1991) 1.50
Assessment of hepatitis C virus RNA and genotype from 6807 patients with chronic hepatitis C in the United States. J Viral Hepat (2000) 1.45
Perinatal transmitted acute icteric hepatitis B in infants born to hepatitis B surface antigen-positive and anti-hepatitis Be-positive carrier mothers. Pediatrics (1982) 1.44
Autoimmune cholangitis with features of autoimmune hepatitis: successful treatment with immunosuppressive agents and ursodeoxycholic acid. J Gastroenterol Hepatol (2000) 1.40
The long-term outcomes of patients with compensated hepatitis C virus-related cirrhosis and history of parenteral exposure in the United States. Hepatology (1999) 1.39
Inhibition of microbial growth by fatty amine catalysts from polyurethane foam test tube plugs. Appl Microbiol (1975) 1.39
Primary hepatocellular carcinoma following perinatal transmission of hepatitis B. West J Med (1988) 1.38
CC-1065 (NSC 298223), a potent new antitumor agent improved production and isolation, characterization and antitumor activity. J Antibiot (Tokyo) (1981) 1.27
Evaluation of hepatitis B and C viral markers: clinical significance in Asian and Caucasian patients with hepatocellular carcinoma in the United States of America. J Gastroenterol Hepatol (1996) 1.21
Epidemiology of the acute fevers of unknown origin in South Vietnam: effect of laboratory support upon clinical diagnosis. Am J Trop Med Hyg (1973) 1.20
A comparative study of hepatitis B viral markers in the family members of Asian and non-Asian patients with hepatitis B surface antigen-positive hepatocellular carcinoma and with chronic hepatitis B infection. J Infect Dis (1979) 1.15
Prevention of maternal-infant hepatitis B virus transmission by immunization: the role of serum hepatitis B virus DNA. Hepatology (1986) 1.13
Melioidosis: a serological survey in military personnel. Mil Med (1973) 1.12
Ascaris lumbricoides--a reminder. Arch Intern Med (1976) 1.09
Inferred natural history of uveal melanoma. Invest Ophthalmol Vis Sci (1980) 1.08
Alterations in the immune response of nonresponders to the hepatitis B vaccine. J Infect Dis (1985) 1.07
Physicochemical and biological properties of sonically treated Vi antigen. J Bacteriol (1967) 1.06
Re-treatment of chronic hepatitis C with consensus interferon . Hepatology (1998) 1.05
Immunological studies in familial primary biliary cirrhosis. Gastroenterology (1976) 1.04
Inhibition of hepatitis C virus (HCV)-RNA-dependent translation and replication of a chimeric HCV poliovirus using synthetic stabilized ribozymes. Hepatology (2000) 1.03
Microtubule assembly is regulated by externally applied strain in cultured smooth muscle cells. J Cell Sci (1998) 1.02
A predictive model for the development of hepatocellular carcinoma, liver failure, or liver transplantation for patients presenting to clinic with chronic hepatitis C. Am J Gastroenterol (1999) 1.01
Liver involvement in sickle cell disease. Medicine (Baltimore) (1985) 1.00
CC-1065 (NSC-298223), a new antitumor antibiotic. Production, in vitro biological activity, microbiological assays and taxonomy of the producing microorganism. J Antibiot (Tokyo) (1978) 1.00
Structure of quinomycin antibiotics. J Antibiot (Tokyo) (1975) 1.00
Biological studies with alpha-dehydrobiotin. J Bacteriol (1969) 0.98
Unimpaired B-cell function and T-cell regulation of immunoglobulin synthesis in patients with chronic hepatitis B virus infection. Clin Immunol Immunopathol (1982) 0.98
The natural course of hepatitis B surface antigen-positive chronic active hepatitis in Taiwan. J Infect Dis (1982) 0.98
Vibrio vulnificus infection after raw oyster ingestion in a patient with liver disease and acquired immune deficiency syndrome-related complex. Gastroenterology (1987) 0.98
Malabsorption in Plasmodium falciparum malaria. Am J Trop Med Hyg (1972) 0.97
Studies on the maternal-infant transmission of the hepatitis B virus and HBV infection within families. Prog Med Virol (1981) 0.97
The structure and absolute configuration of pentalenolactone (PA 132). Tetrahedron Lett (1970) 0.97
Physiochemical properties of the Vi antigen before and after mild alkaline hydrolysis. J Bacteriol (1967) 0.96
Adriamycin and methyl-CCNU combination therapy in hepatocellular carcinoma: clinical and pharmacokinetic aspects. Cancer (1981) 0.95
Two new antimetabolites of biotin: alpha-methyldethiobiotin and alpha-methylbiotin. Antimicrob Agents Chemother (1972) 0.95
A new antitumor antimetabolite, (alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (NSC-163501): antimicrobial reversal studies and preliminary evaluation against L1210 mouse leukemia in vivo. Cancer Chemother Rep (1973) 0.95
Immunological response in leptospirosis. Report of three cases. Am J Trop Med Hyg (1971) 0.95
Pulmonary involvement in primary biliary cirrhosis. J Clin Gastroenterol (1987) 0.94
Comparison of three different hybridization assays in the quantitative measurement of serum hepatitis B virus DNA. J Virol Methods (1996) 0.93
Lean body mass is a predictor of the daily requirement for thyroid hormone in older men and women. J Am Geriatr Soc (1984) 0.93
Risk factors for hepatitis C virus infection among health care personnel in a community hospital. Am J Infect Control (1993) 0.92
Liver transplantation for chronic hepatitis B in Asians. Transplantation (1994) 0.92
Antibiotic sensitivities of shigella isolates in Vietnam, 1968-1969. Mil Med (1970) 0.92
Botryomycosis as an obstructive hepatic disease. Arch Intern Med (1978) 0.92
Effects of short-term, high-dose prednisone treatment of patients with HBsAg-positive chronic active hepatitis. Liver (1985) 0.92
Sonographic findings in testicular sarcoidosis simulating malignant nodule. J Clin Ultrasound (1999) 0.91
In vitro gray scale echography of protein-lipid fluid collections in liver tissue. J Clin Ultrasound (1976) 0.91
Body composition and resting metabolic rate: the myth of feminine metabolism. Am J Clin Nutr (1982) 0.91
Topical anesthetic-induced methemoglobinemia in sheep: a comparison of benzocaine and lidocaine. Fundam Appl Toxicol (1992) 0.91
Early hepatitis C virus-RNA responses predict interferon treatment outcomes in chronic hepatitis C. The Consensus Interferon Study Group. Hepatology (1998) 0.90
Influence of exercise on urea, creatinine, and 3-methylhistidine excretion in normal human subjects. Am J Physiol (1984) 0.90
Factors associated with low birthweight in an inner-city population: the role of financial problems. Am J Public Health (1987) 0.90
An outbreak of avian malaria in captive yellowheads/mohua (Mohoua ochrocephala). N Z Vet J (2008) 0.89
Cholecystosonography in children with sickle cell disease: technical approach and clinical results. J Clin Ultrasound (1981) 0.89
Naturally occurring hepatitis B virus mutants with deletions in the core promoter region. J Hepatol (1994) 0.89
Need for immunoprophylaxis in infants born to HBsAg-positive carrier mothers who are HBeAg negative. J Pediatr (1984) 0.89
Oxygen, ascorbic acid, and the lung. Participation of adrenal ascorbic acid in response to oxygen challenge of the lung. Arch Pathol (1967) 0.89
Sonography of splenic angiosarcoma. J Clin Ultrasound (1985) 0.89
Primary hepatocellular carcinoma and hepatitis B infection during childhood. Hepatology (1987) 0.88
Correlation of e antigen, DNA polymerase activity, and Dane particles in chronic benign and chronic active type B hepatitis infections. J Infect Dis (1977) 0.88
Angina during hemodialysis. Treatment by coronary bypass graft. JAMA (1975) 0.87
Prevalence and risk factors for diabetes mellitus in moderate term survivors of liver transplantation. Am J Transplant (2006) 0.87
Studies on the maternal-infant transmission of the viruses which cause acute hepatitis. Gastroenterology (1981) 0.87
A new antitumor agent, (alphas, 4s, 5r)-alpha-amino-3-chloro-4-hydroxy-4,5-dihydro-5-isoxazoleacetic acid (NSC-176324): preliminary evaluation against L 1210 mouse leukemia in vivo. Cancer Chemother Rep (1975) 0.87
The isolation, structure, and absolute configuration of U-43,795, a new antitumor agent. J Antibiot (Tokyo) (1975) 0.87
Cardiopulmonary effects of a tiletamine-zolazepam combination in sheep. Am J Vet Res (1991) 0.86
Blood coagulation studies in Plasmodium falciparum malaria. Am J Med Sci (1973) 0.86
A serological case-control study of primary hepatocellular carcinoma in Guangxi, China. Cancer Res (1985) 0.86
Clinical, serologic, and immunologic effects of human leukocyte interferon in HBsAg-positive primary hepatocellular carcinoma. Cancer (1985) 0.86
Analysis of the DNA of hepatitis B virus in the sera of Chinese patients infected with hepatitis B. J Infect Dis (1986) 0.85
A hepatitis B vaccination program in a community teaching hospital. Infect Control (1987) 0.85
Closed-circuit metabolic system with multiple applications. J Appl Physiol (1985) (1986) 0.85
Prevention of hepatitis B virus infection in children born to HBsAg positive/HBeAg positive mothers. Preliminary results of active and passive-active immunization. Dev Biol Stand (1983) 0.85
Detection of antibodies to hepatitis E virus in patients with autoimmune chronic active hepatitis and primary biliary cirrhosis. Scand J Gastroenterol (1997) 0.85
Glucose turnover during recovery from intensive exercise. Diabetes (1983) 0.85
Spontaneous reactivation of hepatitis B in Chinese patients with HBsAg-positive chronic active hepatitis. Hepatology (1987) 0.85
Hypercorticosteronuria and diminished pituitary responsiveness to corticotropin-releasing factor in obese Zucker rats. Endocrinology (1986) 0.84
A systems comparison of once- versus twice-daily milking of pastured dairy cows. J Dairy Sci (2006) 0.84
Evidence for clustering of hepatitis B virus infection in families of patients with primary hepatocellular carcinoma. Cancer (1979) 0.84
A pilot study on the effects of prednisone withdrawal on serum hepatitis B virus DNA and HBeAg in chronic active hepatitis B. Hepatology (1987) 0.84